For more than 30 years, CTM has focused on clinical trial enrollment — learning how patients respond, how sites work, and what moves patients from interest to enrollment and then motivates them to stay
Today, that experience powers one integrated enrollment engine that combines technology, nurses for live support, and data intelligence to move better-qualified patients from identification through screening, site referral, randomization, and retention.
The result: a legacy of better qualified referrals, less site burden, faster enrollment, industry-leading results, and unsurpassed client retention.
+
+
+
+
+
Global Enrollment Engine: built for better performance
CTM’s enrollment engine recruits to retain by bringing the people, technology, and intelligence needed to find qualified patients and keep them moving through the trial journey.
One enrollment engine.
Five connected capabilities.
Patient Identification - find and reach patients most likely to qualify
Patient Engagement – nurse-led conversations lend empathy, provide education, and foster confidence and commitment
Screening – several layers of verification of potential eligibility before referral
Site Enablement - reduce site burden by referring pre-qualified patients, ready to enroll
Reporting & Optimization – track patients and performance real-time to continuously optimize recruitment
CTM is different because our enrollment expertise is based on an integration of people, technology, and data intelligence
At the core of what we do, people make the difference
Nurse engagement
Supports patients when they need conversation, clarification, or reassurance
Site support
Helps teams work efficiently and keeps referrals progressing
Patient enrollment experts
Work together, combining institutional knowledge across clinical science, marketing, data analytics, product, and engineering
Explore Clinical Research™: a proprietary community of patients ready for trial engagement
CTM's proprietary community of 3M+ individuals have opted in to match with clinical trials in an extensive range of therapeutic areas.
We help community members better understand clinical research and build increased confidence in participation before the right study opportunity arises.
Ongoing engagement keeps members ready and responsive between studies, improving follow-through when they are matched with a trial.
M+
opted-in community members
RandIQ™: predictive enrollment intelligence, built on decades of learnings from patient journeys
For three decades, CTM has supported more than 3,500 studies across more than 6,300 sites and 80 countries. All the learnings from this experience with real patient and site data is the intelligence that fuels RandIQ, our predictive enrollment solution that helps improve forecasting, predict outcomes, surface risks, and enable proactive planning.
+
studies
+
sites
+
countries
RandIQ helps set CTM up for success, right from the start, and informs optimized future planning and forecasting
Technology built exclusively for clinical trial enrollment
StudyMax is a suite of AI-enabled products that power the CTM enrollment engine
StudyMax is continuously informed by RandIQ insights to inspire new solutions, new software, and new integrations
Built around the patient enrollment journey, StudyMax connects identification, screening, patient engagement, referral management, and tracking in one AI-enabled technology platform, with solutions such as StudyMax Media™, StudyMax Screen™, and StudyMax Retain™.
Real-time visibility to the journey through StudyMax Analytics™ helps CTM do more than report performance — it helps us predict it and improve it.
Results that make a difference
Time is money — CTM accelerates enrollment timelines and can make up for a lag in site enrollments.
CTM consistently enrolls a large percentage of a study’s total enrollment and we do it faster, saving both time and money.
CTM’s patient quality is unmatched in the industry. Our recruit to retain approach means more of our randomized patients complete the study.
Inclusivity is built into CTM’s enrollment engine, making enrolling diversity candidates a natural outcome.
